Cargando…
Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer
Inflammatory bowel disease (IBD) is known to significantly increase the risk for development of colorectal cancer (CRC), suggesting inflammation and cancer development are closely intertwined. Thus, agents that suppress inflammation may prevent the onset of cancer. In the current study, we used resv...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355848/ https://www.ncbi.nlm.nih.gov/pubmed/32526927 http://dx.doi.org/10.3390/jcm9061796 |
_version_ | 1783558370252292096 |
---|---|
author | Alrafas, Haider Rasheed Busbee, Philip Brandon Chitrala, Kumaraswamy Naidu Nagarkatti, Mitzi Nagarkatti, Prakash |
author_facet | Alrafas, Haider Rasheed Busbee, Philip Brandon Chitrala, Kumaraswamy Naidu Nagarkatti, Mitzi Nagarkatti, Prakash |
author_sort | Alrafas, Haider Rasheed |
collection | PubMed |
description | Inflammatory bowel disease (IBD) is known to significantly increase the risk for development of colorectal cancer (CRC), suggesting inflammation and cancer development are closely intertwined. Thus, agents that suppress inflammation may prevent the onset of cancer. In the current study, we used resveratrol, an anti-inflammatory stilbenoid, to study the role of microbiota in preventing inflammation-driven CRC. Resveratrol treatment in the azoxymethane (AOM) and dextran sodium sulphate (DSS) CRC murine model caused an increase in anti-inflammatory CD4 + FOXP3 + (Tregs) and CD4 + IL10 + cells, a decrease in proinflammatory Th1 and Th17 cells, and attenuated CRC development. Gut microbial profile studies demonstrated that resveratrol altered the gut microbiome and short chain fatty acid (SCFA), with modest increases in n-butyric acid and a potential butyrate precursor isobutyric acid. Fecal transfer from resveratrol-treated CRC mice and butyrate supplementation resulted in attenuation of disease and suppression of the inflammatory T cell response. Data also revealed both resveratrol and sodium butyrate (BUT) were capable of inhibiting histone deacetylases (HDACs), correlating with Treg induction. Analysis of The Cancer Genome Atlas (TCGA) datasets revealed increased expression of Treg-specific transcription factor FoxP3 or anti-inflammatory IL-10 resulted in an increase in 5-year survival of patients with CRC. These data suggest that alterations in the gut microbiome lead to an anti-inflammatory T cell response, leading to attenuation of inflammation-driven CRC. |
format | Online Article Text |
id | pubmed-7355848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73558482020-07-23 Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer Alrafas, Haider Rasheed Busbee, Philip Brandon Chitrala, Kumaraswamy Naidu Nagarkatti, Mitzi Nagarkatti, Prakash J Clin Med Article Inflammatory bowel disease (IBD) is known to significantly increase the risk for development of colorectal cancer (CRC), suggesting inflammation and cancer development are closely intertwined. Thus, agents that suppress inflammation may prevent the onset of cancer. In the current study, we used resveratrol, an anti-inflammatory stilbenoid, to study the role of microbiota in preventing inflammation-driven CRC. Resveratrol treatment in the azoxymethane (AOM) and dextran sodium sulphate (DSS) CRC murine model caused an increase in anti-inflammatory CD4 + FOXP3 + (Tregs) and CD4 + IL10 + cells, a decrease in proinflammatory Th1 and Th17 cells, and attenuated CRC development. Gut microbial profile studies demonstrated that resveratrol altered the gut microbiome and short chain fatty acid (SCFA), with modest increases in n-butyric acid and a potential butyrate precursor isobutyric acid. Fecal transfer from resveratrol-treated CRC mice and butyrate supplementation resulted in attenuation of disease and suppression of the inflammatory T cell response. Data also revealed both resveratrol and sodium butyrate (BUT) were capable of inhibiting histone deacetylases (HDACs), correlating with Treg induction. Analysis of The Cancer Genome Atlas (TCGA) datasets revealed increased expression of Treg-specific transcription factor FoxP3 or anti-inflammatory IL-10 resulted in an increase in 5-year survival of patients with CRC. These data suggest that alterations in the gut microbiome lead to an anti-inflammatory T cell response, leading to attenuation of inflammation-driven CRC. MDPI 2020-06-09 /pmc/articles/PMC7355848/ /pubmed/32526927 http://dx.doi.org/10.3390/jcm9061796 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alrafas, Haider Rasheed Busbee, Philip Brandon Chitrala, Kumaraswamy Naidu Nagarkatti, Mitzi Nagarkatti, Prakash Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer |
title | Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer |
title_full | Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer |
title_fullStr | Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer |
title_full_unstemmed | Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer |
title_short | Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer |
title_sort | alterations in the gut microbiome and suppression of histone deacetylases by resveratrol are associated with attenuation of colonic inflammation and protection against colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355848/ https://www.ncbi.nlm.nih.gov/pubmed/32526927 http://dx.doi.org/10.3390/jcm9061796 |
work_keys_str_mv | AT alrafashaiderrasheed alterationsinthegutmicrobiomeandsuppressionofhistonedeacetylasesbyresveratrolareassociatedwithattenuationofcolonicinflammationandprotectionagainstcolorectalcancer AT busbeephilipbrandon alterationsinthegutmicrobiomeandsuppressionofhistonedeacetylasesbyresveratrolareassociatedwithattenuationofcolonicinflammationandprotectionagainstcolorectalcancer AT chitralakumaraswamynaidu alterationsinthegutmicrobiomeandsuppressionofhistonedeacetylasesbyresveratrolareassociatedwithattenuationofcolonicinflammationandprotectionagainstcolorectalcancer AT nagarkattimitzi alterationsinthegutmicrobiomeandsuppressionofhistonedeacetylasesbyresveratrolareassociatedwithattenuationofcolonicinflammationandprotectionagainstcolorectalcancer AT nagarkattiprakash alterationsinthegutmicrobiomeandsuppressionofhistonedeacetylasesbyresveratrolareassociatedwithattenuationofcolonicinflammationandprotectionagainstcolorectalcancer |